drugset / Trial / NCT01247064

Hypertonic Saline for Acute Bronchiolitis

NCT01247064 ↗

Phase 4 Completed 62 enrolled Children's Hospital of Philadelphia
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether nebulized 3% hypertonic saline (HS) improves respiratory distress in children 2-23 months presenting to the emergency department (ED) with acute bronchiolitis with persistent respiratory distress after initial therapy with a trial of nebulized albuterol.

Timeline

Start
2010-10
Primary completion
2011-12
Completion
2011-12

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Nebulized 3% Saline vs Nebulized 0.9% Normal Saline; p = 0.01; t-test, 2 sided NCT01247064 ↗

paper the HS group demonstrated significantly less improvement in the median Respiratory Assessment Change Score compared with the NS group PMID 24862342 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown 3 % Inhaled
Subject Hypertonic saline Unknown 4 ml Inhaled

Indications